Registration
Daily Coverage
Industry Highlights
Meeting Program
Industry Highlights
Cetaphil, the Leaders in Sensitive Skin Health
Cetaphil is committed to advancing skin science to provide your patients with the best sensitive skincare.
Paid Advertising Content
Join Pfizer | Product Session on Saturday, March 26 between 10:30 a.m. and 11:15 a.m. ET
Paid Advertising Content
Taking the Flare out of Atopic Dermatitis: The Role of Systemic Therapies in Children
Paid Advertising Content
At Pfizer, We're Committed to Helping Accelerate Equity in Dermatology
Paid Advertising Content
Learn About A Now Approved Oral Rx Treatment for Moderate-to-Severe Atopic Dermatitis
Paid Advertising Content
Cetaphil, the Leaders in Sensitive Skin Health
Cetaphil is committed to advancing skin science to provide your patients with the best sensitive skincare.
Paid Advertising Content
Bench to clinic: Innovations in immunodermatology and emerging treatment approaches
World-leading experts discuss what's to come for atopic dermatitis, hidradenitis suppurativa, and psoriasis.
Sponsored
Read all about it
Paid Advertising Content
Alopecia Areata: What You Need to Know
Join Pfizer for an industry session on Sunday, March 27, 10:30-11:15 am.
Industry Highlights
Under the surface: Exploring the pathophysiology and unmet needs in patients with psoriasis
Sunday, March 27
Industry Highlights
Advances in chronic spontaneous urticaria: Expert insight on translating progress to practice for improved symptom control and quality of life
Sunday, March 27
Industry Highlights
Addressing the burden of prurigo nodularis: Expert insight on disease pathogenesis and the clinical potential of novel therapeutic options
Saturday, March 26
Industry Highlights
Advancements in atopic dermatitis: Understanding the role of IL-13 and clinical decisions in adult atopic dermatitis
Saturday, March 26
Industry Highlights
Advances in understanding alopecia areata and the challenge of special body areas in psoriasis
Saturday, March 26
Industry Highlights
The impact of immunotherapy in patients with advanced non-melanoma skin cancer: Focusing in on patient identification and treatment optimization
Friday, March 25
Industry Highlights
Challenging AD expectations: A new therapy option that challenges treatment goals for patients with refractory, moderate to severe atopic dermatitis (AD) who are not adequately controlled with other systemic drug products
Friday, March 25
Industry Highlights
Understanding kinases: From the role of TYK2 in psoriasis pathogenesis to the functional implications of kinase structures
Industry Highlights
Don’t miss the latest from industry at the 2022 AAD Annual Meeting!
Industry Highlights
Targeting new pathways in alopecia areata: The role of JAK inhibitors
Industry Highlights
Discover Options for Selling your Practice
Industry Highlights
AAD Career Networking Event
Industry Highlights
Inclusivity in Dermatology
Industry Highlights
Save the date for 2022 AAD Innovation Academy
Industry Highlights
Your go-to dermatology podcast!
Industry Highlights
Create Efficiency. Stay Compliant. Train your Team.
Industry Highlights
DataDerm Special Events during the 2022 AAD Annual Meeting
Industry Highlights
Experience the the AAD Resource Center Booth 2529
